Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology

AM Hersh, S Alomari, BM Tyler - International journal of molecular …, 2022 - mdpi.com
The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

[HTML][HTML] Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities

PI Siafaka, NÜ Okur, ID Karantas, ME Okur… - Asian Journal of …, 2021 - Elsevier
In the last decade, the use of nanotheranostics as emerging diagnostic and therapeutic tools
for various diseases, especially cancer, is held great attention. Up to date, several …

Occupancy detection in non-residential buildings–A survey and novel privacy preserved occupancy monitoring solution

J Ahmad, H Larijani, R Emmanuel… - Applied Computing …, 2021 - emerald.com
Buildings use approximately 40% of global energy and are responsible for almost a third of
the worldwide greenhouse gas emissions. They also utilise about 60% of the world's …

Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner

M Nehra, UT Uthappa, V Kumar, R Kumar… - Journal of Controlled …, 2021 - Elsevier
There are numerous investigated factors that limit brain cancer treatment efficacy such as
ability of prescribed therapy to cross the blood-brain barrier (BBB), tumor specific delivery of …

Quantum dots: The cutting-edge nanotheranostics in brain cancer management

P Chakraborty, SS Das, A Dey, A Chakraborty… - Journal of Controlled …, 2022 - Elsevier
Quantum dots (QDs) are semiconductor nanocrystals possessing unique optoelectrical
properties in that they can emit light energy of specific tunable wavelengths when excited by …

Bioengineered carboxymethylcellulose–peptide hybrid nanozyme cascade for targeted intracellular biocatalytic–magnetothermal therapy of brain cancer cells

AAP Mansur, SM Carvalho, LCA Oliveira… - Pharmaceutics, 2022 - mdpi.com
Glioblastoma remains the most lethal form of brain cancer, where hybrid nanomaterials
biofunctionalized with polysaccharide peptides offer disruptive strategies relying on …

Polymer-based hybrid nanoarchitectures for cancer therapy applications

A Kumar, M Sharipov, A Turaev, S Azizov, I Azizov… - Polymers, 2022 - mdpi.com
Globally, cancer is affecting societies and is becoming an important cause of death.
Chemotherapy can be highly effective, but it is associated with certain problems, such as …

Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery

Z Nozhat, S Heydarzadeh, M Shahriari-Khalaji… - Biomaterials …, 2023 - pubs.rsc.org
Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-
stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs …

Smart nanoformulations for brain cancer theranostics: challenges and promises

F Ahmad, R Varghese, S Panda, S Ramamoorthy… - Cancers, 2022 - mdpi.com
Simple Summary Brain metastases are amongst the most invasive and lethal cancers. Yet,
effective methods for their diagnosis and therapy have remained elusive. While several …

Natural polysaccharide carriers in brain delivery: challenge and perspective

M Curcio, G Cirillo, JRC Rouaen, F Saletta… - Pharmaceutics, 2020 - mdpi.com
Targeted drug delivery systems represent valuable tools to enhance the accumulation of
therapeutics in the brain. Here, the presence of the blood brain barrier strongly hinders the …